| Literature DB >> 31020107 |
Muhammad Azam Shah1, Abdulaziz Ali Ahmed Alghamdi2, Saif Hasan Alogabey1,2, Mohammad Bara Qattea1,2, Iftikhar Ahmed Bajwa3.
Abstract
INTRODUCTION: Congenital heart defects predispose patients to a significantly increased risk of infective endocarditis (IE), and the incidence is even greater in the immunocompromised population. The involvement of multiple valves leads to a higher rate of complications and thus mortality. Moreover, biventricular IE is an uncommon condition with no specific guidelines for treatment. CASEEntities:
Keywords: Biventricular; Case report; Embolization; Infective endocarditis; Mural; Ventricular septal defect
Year: 2018 PMID: 31020107 PMCID: PMC6426001 DOI: 10.1093/ehjcr/yty031
Source DB: PubMed Journal: Eur Heart J Case Rep ISSN: 2514-2119
| Weeks | Major events |
|---|---|
| Day 1 | Admission to emergency room with longstanding fever, New York Heart Association functional class II/III dyspnoea and weight loss |
| Week 1 |
Initial stabilization Blood cultures and prophylactic antibiotics Transthoracic echocardiography (TTE), transoesophageal echocardiography (TEE), computed tomography (CT) chest, CT abdomen pelvis, and CT brain |
| Week 2 |
Repeated blood cultures turned out negative TTE and TEE repeated to assess vegetations and ventricular functions |
| Week 3 | Surgery: aortic and pulmonary valve replacement, mitral valve repair with ventricular septal defect closure |
| Week 4 | Post-operative intense care unit stay |
| Week 5–6 | Difficult anticoagulation management Completion of 6 weeks of antibiotics Discharge |
Laboratory investigations done at presentation and after 1 week of antibiotics
| Normal values | At presentation | After 1 week | |
|---|---|---|---|
| White cell count (109/L) | 3.9–11 | 8.48 | 9.81 |
| Neutrophils (%) | 30–70 | 68.70 | 61.70 |
| Eosinophils (%) | 1–12 | 0.20 | 1.40 |
| Platelet count (109/L) | 155–435 | 479 | 434.00 |
| Haemoglobin (g/dL) | 11–16 | 9.70 | 9.80 |
| CRP (mg/L) | <3 | 3.1 | NA |
| INR | 0.81–1.23 | 1.4 | 1.2 |
| ALT (U/L) | 0–55 | 66 | 55 |
CRP, C-reactive protein; INR, international normalized ratio; NA, not available.